Latest Breaking News On - Saurabh saha - Page 1 : comparemela.com

Centessa Begins Narcolepsy Drug Candidate ORX750 Trials

Centessa recently initiated the phase 1 clinical trial of ORX750, an orexin receptor 2 agonist in development for narcolepsy treatment.

Saurabh-saha
Centessa-pharmaceuticals
Drug-administration
Investigational-new-drug
Chief-executive-officer

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Ukraine
United-kingdom
Boston
Massachusetts
United-states
Russia
London
City-of
Oberland
Thün
Germany
Kristenk-sheppard

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Ukraine
United-states
United-kingdom
London
City-of
Boston
Massachusetts
Russia
Kristenk-sheppard
Upcoming-program-milestones
Exchange-commission

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

BOSTON and LONDON, April 22, 2024 Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today.

London
City-of
United-kingdom
Russia
Ukraine
Boston
Massachusetts
United-states
Kristenk-sheppard
Exchange-commission
Centessa-pharmaceuticals

FDA OKs Phase 1 Trial of Narcolepsy Drug Candidate ORX750

Centessa has received FDA clearance to start a phase 1 trial of ORX750, aimed at narcolepsy and other sleep-wake disorders.

Saurabh-saha
Centessa-pharmaceuticals
Drug-administration
Centessa-pharmaceutical
Wakefulness-test
Karolinska-sleepiness-scale
Investigational-new-drug